Core Viewpoint - Haijia Medical announced that it expects to achieve a quarter-on-quarter increase in revenue and patient visits in the second half of 2025, indicating a marginal improvement in operational performance [1] Financial Performance - The company's operating cash flow for the year is projected to be between RMB 940 million and RMB 1 billion, representing a year-on-year growth of approximately 33% to 41% [1] - The net bank debt is expected to decrease by RMB 340 million by the end of 2025, with capital expenditures anticipated to decline by 16% to 24% year-on-year [1] Operational Quality - The company is solidifying its operational quality, with ongoing construction projects nearing completion, which may further reduce future capital expenditure [1] - The apparent net profit has decreased primarily due to goodwill impairment, which is a one-time accounting adjustment and does not involve actual cash outflow [1]
海吉亚医疗：2025年下半年经营持续改善 经营性现金流大增超33%